Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 297 JPY -1.91% Market Closed
Market Cap: ¥393.8B

Net Margin

7.1%
Current
Declining
by 2%
vs 3-y average of 9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.1%
=
Net Income
¥11.5B
/
Revenue
¥163.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.1%
=
Net Income
¥11.5B
/
Revenue
¥163.2B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
393.8B JPY
Loading...
FR
L'Oreal SA
PAR:OR
209.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
114.4B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
35.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
36.1B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
22.7B EUR
Loading...
JP
Kao Corp
TSE:4452
3T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
901.4B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

In line with most companies in Japan
Percentile
62st
Based on 6 917 companies
62st percentile
7.1%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
393.8B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
5 462.13 JPY
Undervaluation 3%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.1%
=
Net Income
¥11.5B
/
Revenue
¥163.2B
What is Kobayashi Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Kobayashi Pharmaceutical Co Ltd is 7.1%, which is below its 3-year median of 9%.

How has Net Margin changed over time?

Over the last 3 years, Kobayashi Pharmaceutical Co Ltd’s Net Margin has decreased from 11.9% to 7.1%. During this period, it reached a low of 6% on Sep 30, 2024 and a high of 12.3% on Sep 30, 2023.

Back to Top